Live feed
Filing
SC 13D/A
SC 13D/A0000947871-23-000625·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
Prelude Therapeutics, Inc.
Security class unavailable · CUSIP: 74065P101
Event date: 2023-05-22
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 15,716,642
- Percent of class
- 28.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-23-000625
- Form type
- SC 13D/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- May 24, 2023
- Reporting period
- May 22, 2023
- Description
- Schedule 13D beneficial ownership